Skip to main content

Zenyum

ServiceSingapore, SingaporeFounded 2018· One of 2188 Service companies tracked by AMPulse

A leading Asian dental technology company providing affordable 3D-printed clear aligners and a comprehensive portfolio of 'Smile Cosmetics' through a tech-enabled clinical network.

CEO / Founder
Julian Artopé
Team Size
51-200
Stage
Subsidiary
Total Funding
$56M
Latest Round
Series B
Key Investors
L Catterton, Peak XV Partners (formerly Sequoia India), RTP Global, Partech, TNB Aura, Seeds Capital, FEBE Ventures

Technology & Products

Key Products

Zenyum offers 3D-printed clear aligners and Smile Cosmetics oral care products. ZenyumClear Ultra, announced September 17, 2026, extends treatment to complex malocclusions using multilayer medical-grade polymer and auxiliary treatments.

Technological Advantage

Proprietary mobile app for remote treatment monitoring and AI-driven pre-screening, combined with a localized regional network of over 500 partner clinics and high-precision 3D printing (Polymer AM) manufacturing workflows.

Differentiation

Value Proposition

Delivers professional-grade orthodontic results at up to 70% lower cost than traditional braces by utilizing a proprietary tech stack to minimize clinic visits while maintaining dentist oversight.

How They Differentiate

Pioneered the 'Smile Cosmetics' category by blending professional orthodontic care with a lifestyle brand identity. Differentiates through a hybrid model that requires mandatory initial dentist consultations while utilizing a proprietary app for remote monitoring, offering treatments at 70% lower costs than traditional braces.

Market & Competition

Target Customers

The rising Asian middle class, specifically Gen Z and Millennials seeking accessible, aesthetic orthodontic treatments and premium oral care.

Industry Verticals

HealthTech, Dental Care / Orthodontics, Direct-to-Consumer (D2C), Consumer Goods (Personal Care)

Competitors

Invisalign, WonderSmile, Smile Direct Club, Dr Clear Aligners

Growth & Milestones

Growth Metrics

Historical metrics: reported 4x revenue growth in 2020, EBITDA profitability in its largest markets and an eightfold improvement in lead activation. On October 13, 2026, Zenyum reported that the combined MakeO–Zenyum group had approximately 1,100 partner dentists, more than US$55M annual recurring revenue and EBITDA profitability; these are group-level figures.

Major Milestones

Selected for Sequoia India's Surge accelerator program in 2019, Expanded operations to 7 Asian markets within three years of founding, Secured $40M Series B led by L Catterton in 2021, Announced strategic merger with MakeO Toothsi on February 11, 2026, with completion expected by end-February pending approvals, Became part of MakeO in 2026; official site now identifies MakeO as Zenyum's parent, Announced ZenyumClear Ultra on September 17, 2026, Parent MakeO announced US$10M funding led by Singularity AMC on October 13, 2026; this is parent-level funding, not a standalone Zenyum round

Recent coverage of Zenyum

Funding rounds

  • Series B$40.0M2021-06Lead: L Catterton · Source: TechCrunch
  • Series A$13.6M2019-11Lead: RTP Global · Source: TechCrunch
  • Seed$1.5M2019-04Lead: Peak XV Partners · Source: Crunchbase

Why this company matters

AMPulse analysis, not a company disclosure

Zenyum positions itself as a consumer-tech dental platform rather than a pure orthodontic provider, having pioneered the 'Smile Cosmetics' category that reframes dental care as a lifestyle choice. Founded in 2018, the company targets Gen Z and Millennials across Asia with affordable clear aligners and a branded oral care product line, competing against Invisalign, Smile Direct Club, and regional players like WonderSmile and Dr Clear Aligners.

The core service relies on VPP-SLA 3D printing to manufacture clear aligners in-house, supported by an AI-driven mobile app for remote treatment monitoring and pre-screening. Unlike fully direct-to-consumer models, Zenyum requires mandatory initial consultations at a network of over 500 licensed partner clinics across nine Asian markets, blending D2C convenience with professional oversight. The company also offers a broader portfolio of 'Smile Cosmetics' oral care products sold through e-commerce channels.

Zenyum's strategic moat lies in its hybrid clinical-tech model and regional scale. A 2024 merger with India's MakeO (Toothsi) created what the company claims is Asia's largest clinical-tech dental platform. Key partnerships include Salesforce and Shopee for customer engagement, Appier for AI-driven marketing automation, and INSEAD for professional development of partner dentists. The company reported a 4x revenue increase in 2020 and achieved EBITDA profitability in its largest markets, though the long-term competitive risk includes potential margin pressure from low-cost aligner entrants and the capital intensity of maintaining a physical clinic network.